Project Grant R43DA059290

Award Date 9/15/23
Completion Date 7/31/24
Dollars Obligated $275K
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Virginia, USA
Similar Awards
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $594,122 to Boulder Care, Inc. to develop and test telehealth workflows for delivering buprenorphine treatment for opioid use disorder (OUD) in vulnerable settings. The project aims to address barriers to OUD treatment access by providing smartphones and connectivity to individuals in high-risk situations, such as jails/prisons, emergency...
This $857,121 Project Grant award from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) aims to develop and test a prototype mobile health application called R-ASSIST. The app is designed to support individuals with co-occurring opioid use and mental health disorders who are transitioning from jail to the community. Key features of the R-ASSIST app include daily symptom and medication monitoring, a self-help curriculum, a social determinants of health...
This $773,000 Project Grant award from the Agency for Healthcare Research and Quality (AHRQ) under the Research on Healthcare Costs, Quality and Outcomes (CFDA 93.226) program will fund the adaptation and evaluation of a digital health intervention called MEDSMAT Mobile. This intervention incorporates an evidence-based serious game, MEDSMAT: Adventures in Pharmacity, and a personalized family medication safety plan to promote opioid safety communication between adolescents and their parents. The...
This federal Project Grant award of $1,948,634.00 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will fund the development and evaluation of a mobile health (mHealth) intervention called "OD-CHESS" to reduce overdose risk among people who engage in polysubstance use. The research project, awarded to the Research Triangle Institute (RTI International), will first adapt an existing substance use disorder intervention...
This $3,189,610 federal Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will develop and test a novel "Hub and Spoke" model to implement prevention and harm reduction services in rural clinics. The "Coalition for Harm Reduction and Prevention (CHRP)" model aims to help rural outpatient clinics adopt effective substance use disorder prevention and harm reduction interventions, with a focus on...
This $591,752 Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to evaluate the feasibility and effectiveness of integrating electronic screening tools into a digital platform to identify patient risk of opioid misuse and overdose. The project, led by Oprems LLC, will provide tablet computers with the digital screening platform to community pharmacies currently using a paper-based screening tool. The...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will fund the development and evaluation of a mobile health intervention for individuals with co-occurring opioid use disorder (OUD) and post-traumatic stress disorder (PTSD) during community re-entry after residential OUD treatment. The $2,729,018 award will support a multi-year study to rigorously develop and test a mobile app that provides 24/7 access to...
This federal Project Grant award of $3,503,736 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to develop and test a multilevel substance use disorder (SUD) and overdose prevention strategy for rural youth involved in county legal systems. The key products and services to be delivered under this 2-year R61 phase and 3-year R33 phase award include: 1) co-designing a multilevel SUD/overdose prevention strategy with...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will pilot an innovative digital Contingency Management (CM) treatment delivered via mobile device to Medicaid beneficiaries with co-occurring opioid and alcohol use disorders. The $390,000 award, spanning from September 2024 to August 2027, aims to: 1) identify optimal approaches to engage Medicaid beneficiaries in digital CM through Medicaid claims data...
This Project Grant award, with a total funding amount of $958,629, was awarded by the National Institute on Drug Abuse (NIDA) under the Drug Abuse and Addiction Research Programs (CFDA 93.279). The funding will support the real-world adoption of an innovative digital health therapeutic called KIOS, which uses nonlinear control theory to track multiple symptoms (e.g., craving, mood, pain) and deliver personalized, evidence-based intervention strategies to patients with opioid use disorder...

AN MHEALTH APPROACH TO DECREASING OPIOID ABUSE AND OTHER DISEASES OF DESPAIR IN RURAL POPULATIONS - PROJECT SUMMARY/ABSTRACT RURAL AMERICANS FACE NUMEROUS HEALTH DISPARITIES COMPARED TO THEIR URBAN COUNTERPARTS AND ARE MORE LIKELY TO DIE FROM CHRONIC HEALTH CONDITIONS, INCLUDING SUBSTANCE ABUSE. INDEED, OPIOID-RELATED MORTALITY IS HIGHEST IN CERTAIN RURAL AREAS OF THE U.S., INCLUDING APPALACHIA, NEW ENGLAND, AND THE MOUNTAIN WEST. A NUMBER OF STUDIES LOOKING AT MORBIDITY AND MORTALITY PROVIDE INSIGHT INTO THE HEALTH PROBLEMS AFFLICTING LESS EDUCATED, RURAL POPULATIONS.6-9,14-15 LACK OF HIGH SCHOOL DIPLOMA, MENTAL ILLNESS, ALCOHOL USE, AND ILLICIT DRUG USE WERE ALL SUBSTANTIALLY HIGHER IN THE POPULATION OF DECEDENTS, AND INDIVIDUALS SUFFERING FROM THESE PROBLEMS ARE AT HEIGHTENED RISK FOR OPIOID MISUSE.22-29 THE PURPOSE OF THIS PROJECT IS TO DEVELOP A MOBILE-BASED OPIOID PREVENTION PROGRAM FOR RURAL-BASED BLUE-COLLAR WORKERS THAT PROVIDES ROBUST PREVENTIVE INTERVENTIONS AIMED AT REDUCTION IN ALCOHOL CONSUMPTION, MANAGEMENT OF NEGATIVE MOOD STATES INCLUDING ANXIETY AND DEPRESSION, AND NON-PHARMACOLOGIC APPROACHES TO MANAGING PAIN. THE PROGRAM AIMS TO FILL AN IMPORTANT GAP IN SERVICE PROVISION TO RURAL ADULTS AT RISK FOR OPIOID MISUSE. THE PROGRAM WILL CAPITALIZE ON TECHNOLOGIES AVAILABLE IN RURAL COMMUNITIES - NAMELY MOBILE HEALTH - AND WILL BE MEDIA RICH, INCLUDING A PROGRAM 'COACH' AND VIDEOS OF INDIVIDUALS THAT USERS CAN RELATE TO DESCRIBING THEIR EXPERIENCES DEALING WITH PAIN, SUBSTANCE USE DIFFICULTIES, STRESS AND MOOD ISSUES - AND THE IMPACT OF THESE ISSUES ON THEIR LIVES. SIMILAR TO OTHER HEALTH PROMOTION AND SUBSTANCE ABUSE PREVENTION PROGRAMS DEVELOPED BY OUR GROUP, THE PROGRAM WILL BE HIGHLY INDIVIDUALIZED - TAILORED BY USER CHARACTERISTICS AND EXPERIENCES, DIRECTING USERS TO MANAGEMENT OF DIFFICULT MOODS, TECHNIQUES IN THE SELF-MANAGEMENT OF PAIN, AND AVOIDANCE OF ABUSING ALCOHOL AND OTHER SUBSTANCES, INCLUDING OPIOIDS. IN PHASE I, WITH CRUCIAL INPUT FROM TWO FOCUS GROUPS AND OUR EXPERT CONSULTANTS, ISA STAFF WILL DEVELOP AND PILOT TEST A MOBILE OPIOID MISUSE PREVENTION PROGRAM EMBEDDED WITHIN A LARGER HEALTH PROMOTION PROGRAM. PRE-DEVELOPMENT FOCUS GROUPS WILL BE CONDUCTED WITH INDIVIDUALS WHO WILL BE RECRUITED TO HELP SHAPE THE STRUCTURE AND CONTENT OF THE PROGRAM. ISA STAFF AND THE REDMON GROUP WILL DEVELOP THE PROTOTYPE PROGRAM, FULLY DEVELOPING THE INTRODUCTION, AND EXTENSIVE SECTIONS OF MY HEALTH PROFILE, UNDERSTANDING AND MANAGING MOODS, AND TAKING CARE OF YOURSELF - NEVER GIVE UP! FOR PHASE I. FOLLOWING DEVELOPMENT AND EXPERT REVIEW OF THE PROTOTYPE PROGRAM, 20 END USERS WILL BE ASKED TO PILOT TEST THE PROGRAM, INCLUDING A USABILITY TEST, QUANTITATIVE RATING OF THE PROGRAM, AND INTERVIEW ABOUT THEIR EXPERIENCE USING THE PROGRAM. TO ADVANCE TO PHASE II, THERE MUST BE AN 80% ERROR-FREE RATE AND QUANTITATIVE RATINGS MUST BE 4 OR HIGHER FOR ALL ITEMS.

Posted 9/5/23, 12:00 AM